Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 66 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
the Minnesota Ovarian Cancer Alliance
Grant: P50 CA136393-11A1
the Minnesota Ovarian Cancer Alliance
Grant: P30 CA077598
the Minnesota Ovarian Cancer Alliance
Grant: UL1-TR002494
the Minnesota Ovarian Cancer Alliance
Grant: 5 U01 CA200462-02
the Minnesota Ovarian Cancer Alliance
Grant: P50 CA83639
the Minnesota Ovarian Cancer Alliance
Grant: P50CA217685
the Minnesota Ovarian Cancer Alliance
Grant: RP160145
the Minnesota Ovarian Cancer Alliance
Grant: IG-21320
the Minnesota Ovarian Cancer Alliance
Grant: RF-2016-02362551
the Minnesota Ovarian Cancer Alliance
Grant: NCI P30 CA6927
the Minnesota Ovarian Cancer Alliance
Grant: NIH S10 ODO21760
NIH HHS
Grant: S10 OD021760
NCI NIH HHS
Grant: U01 CA200462
NCI NIH HHS
Grant: P50 CA083639
NCATS NIH HHS
Grant: UL1 TR002494
NCI NIH HHS
Grant: P30 CA006927
NCI NIH HHS
Grant: P50 CA136393
National Institutes of Health
Grant: 2U01CA200462-06A1
MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm
National Institutes of Health
Grant: 5P50CA083639-10
Targeting the PI3K Pathway in Ovarian Cancer
National Institutes of Health
Grant: 5P30CA006927-49
Transgenic Mouse
National Institutes of Health
Grant: 5P30CA077598-08
Cancer Center Support Grant P30 CA77598-06
National Institutes of Health
Grant: 1P50CA217685-01
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
National Institutes of Health
Grant: 3UL1TR002494-02S1
University of Minnesota Clinical and TranslationalmScience Institute (UMN CTSI)
National Institutes of Health
Grant: 5P50CA136393-10
Mayo Clinic Ovarian Cancer SPORE
FWCI
13.73
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 1 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 33 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 33 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 34 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 34 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 31 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 31 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 32 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 32 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 28 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 29 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 30 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 30 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 27 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 29 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 26 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 27 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 28 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay
Additional file 25 of Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay